HQY Healthequity Inc

Price (delayed)

$77.03

Market cap

$6.7B

P/E Ratio

82.83

Dividend/share

N/A

EPS

$0.93

Enterprise value

$7.43B

HealthEquity and its subsidiaries administer HSAs and other consumer-directed benefits for its more than 12 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers who ...

Highlights
The P/E is 62% lower than the last 4 quarters average of 216.2
HQY's net income is up by 44% since the previous quarter
HQY's quick ratio is down by 11% since the previous quarter but it is up by 7% year-on-year
The debt has increased by 5% since the previous quarter and by 4.4% year-on-year

Key stats

What are the main financial stats of HQY
Market
Shares outstanding
87.01M
Market cap
$6.7B
Enterprise value
$7.43B
Valuations
Price to book (P/B)
3.16
Price to sales (P/S)
6.39
EV/EBIT
49.39
EV/EBITDA
24.5
EV/Sales
7.13
Earnings
Revenue
$1.04B
EBIT
$150.52M
EBITDA
$303.5M
Free cash flow
$229.21M
Per share
EPS
$0.93
Free cash flow per share
$2.65
Book value per share
$24.35
Revenue per share
$12.06
TBVPS
$6.09
Balance sheet
Total assets
$3.25B
Total liabilities
$1.15B
Debt
$983.68M
Equity
$2.1B
Working capital
$312.69M
Liquidity
Debt to equity
0.47
Current ratio
4.39
Quick ratio
3.88
Net debt/EBITDA
2.41
Margins
EBITDA margin
29.1%
Gross margin
63.5%
Net margin
7.7%
Operating margin
13.1%
Efficiency
Return on assets
2.6%
Return on equity
4%
Return on invested capital
13.6%
Return on capital employed
4.8%
Return on sales
14.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

HQY stock price

How has the Healthequity stock price performed over time
Intraday
0.71%
1 week
-5.57%
1 month
-6.61%
1 year
23.82%
YTD
16.18%
QTD
-10.64%

Financial performance

How have Healthequity's revenue and profit performed over time
Revenue
$1.04B
Gross profit
$661.95M
Operating income
$136.15M
Net income
$80.43M
Gross margin
63.5%
Net margin
7.7%
Healthequity's operating margin has soared by 198% YoY and by 11% from the previous quarter
HQY's net income is up by 44% since the previous quarter
The net margin has increased by 38% since the previous quarter
The gross profit rose by 25% year-on-year and by 6% since the previous quarter

Growth

What is Healthequity's growth rate over time

Valuation

What is Healthequity stock price valuation
P/E
82.83
P/B
3.16
P/S
6.39
EV/EBIT
49.39
EV/EBITDA
24.5
EV/Sales
7.13
The P/E is 62% lower than the last 4 quarters average of 216.2
HQY's EPS is up by 43% since the previous quarter
The equity has grown by 9% YoY and by 3.1% from the previous quarter
The stock's P/B is 4.8% below its 5-year quarterly average of 3.3
HQY's revenue is up by 16% year-on-year and by 4.3% since the previous quarter
The stock's price to sales (P/S) is 14% less than its 5-year quarterly average of 7.4

Efficiency

How efficient is Healthequity business performance
HQY's return on sales has surged by 200% year-on-year and by 10% since the previous quarter
The ROA has grown by 44% from the previous quarter
The ROE has grown by 43% from the previous quarter
HQY's ROIC is up by 13% QoQ

Dividends

What is HQY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HQY.

Financial health

How did Healthequity financials performed over time
Healthequity's total assets is 183% higher than its total liabilities
HQY's quick ratio is down by 11% since the previous quarter but it is up by 7% year-on-year
Healthequity's current ratio has increased by 10% YoY but it has decreased by 8% QoQ
The debt is 53% smaller than the equity
The equity has grown by 9% YoY and by 3.1% from the previous quarter
The debt has increased by 5% since the previous quarter and by 4.4% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.